Groundbreaking Study by Dr. Agarwal’s Eye Hospital on post-crosslinking surgery patients Wins ‘Best Scientific Poster Award’ at ASCRS 2024 Annual Meeting
Dr Agarwal’s Eye Hospital recently announced that their accomplished research team have been honoured with the prestigious ‘Best Scientific Poster Award’ at the 2024 Annual Meeting of the American Society for Cataract and Refractive Surgery (ASCRS). This recognition comes in…
Landmark Non-inferiority Clinical Trial Demonstrates Nanodropper’s Positive Impact on Glaucoma Treatment
Nanodropper, Inc., an ophthalmic device company that created the eyedrop volume-reducing Nanodropper® Adaptor, announced today that its clinical trial “An Evaluation of the Efficacy and Safety of Timolol Maleate 0.5% Microdrops Administered with the Nanodropper” was published in the journal Ophthalmology. This was a…
PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients.
PolyActiva is a Melbourne-based ophthalmology company developing a novel proprietary drug delivery platform. Today the company reported promising interim results from an ongoing Phase 2a clinical study for its PA5108 Ocular Implant in subjects with mild to moderate glaucoma. This ocular implant is…
First patient treated in the second dose group in Annexin’s RVO study
Annexin Pharmaceuticals announces that all patients in the first dose group with the lowest dose have now completed treatment in the company’s clinical phase 2 study in patients with retinal vein occlusion (RVO) with the investigational drug candidate ANXV. No…
The Inner Circle Acknowledges, , Lawrence J. Singerman as a Most Trusted Healthcare Professional for his contributions to the Field of Ophthalmology
The Inner Circle Acknowledges, , Lawrence J. Singerman as a Most Trusted Healthcare Professional for his contributions to the Field of Ophthalmology. Dr. Singerman earned a Bachelor of Science degree in Psychology from Case Western Reserve University, and a Medical Degree…
GUERISON to Set-Up its Footprints in India’s Ophthalmology Market
GUERISON, a global pharmaceutical having a surgical business concept incepted in Dubai, is setting its footprints in India’s Ophthalmology market with the highest ethics, top development, and uttermost safety standards!! Here, the values are extraordinary, and the planning is exceptional….
